Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

The year had a lot to celebrate, but there were certain pop culture occasions that had us cringing Alex Apatoff is the Managing Editor, Special Integrated Products at People, where she has worked for ...

The good, the bad and the WTF style moments celebrities served up this week Catherine Santino is a Style Writer-Reporter at PEOPLE. She began as a contributor for PEOPLE in 2022 and joined the staff ...

Minnie Mouse tells you that the Phonograph the Fairy Godmother enchanted seems to be having issues. Head to her home and take a picture of the problem. Speak with the Fairy Godmother. She will thank ...

Gear-obsessed editors choose every product we review. We may earn commission if you buy from a link. Why Trust Us? The Paris Climate Accords in 2015 set an ambitious (and necessary) goal of keeping ...

The Paris Climate Accords in 2015 set an ambitious (and necessary) goal of keeping global temperatures at 1.5 degrees Celsius above pre-industrial temps. But a study says we might’ve blown past that ...